Ovation Science Inc., a leading innovator in the biotechnology sector, is headquartered in California and operates primarily across North America. Founded in 2014, the company has made significant strides in the development of transdermal delivery systems, particularly for cannabinoid-based products. Ovation's core offerings include its patented formulations that enhance the absorption of active ingredients through the skin, setting it apart in the competitive landscape of cannabis and wellness products. With a commitment to quality and efficacy, the company has established a strong market position, recognised for its scientific approach and dedication to research and development. As Ovation Science continues to expand its product line and operational reach, it remains at the forefront of innovation in the cannabis industry, striving to improve consumer health and wellness through advanced delivery technologies.
How does Ovation Science Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ovation Science Inc.'s score of 26 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ovation Science Inc., headquartered in Canada, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, Ovation Science Inc. may inherit climate-related data and initiatives from its parent organization, but no specific details have been provided regarding such cascaded information. The absence of emissions data and reduction initiatives highlights a potential area for improvement in the company's environmental strategy. In the broader context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate impact. Ovation Science Inc. may benefit from aligning with these trends to enhance its climate commitments and transparency in emissions reporting.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ovation Science Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
